Inhibitors of checkpoint kinases

Details for Australian Patent Application No. 2006335111 (hide)

Owner Merck & Co., Inc.

Inventors Brnardic, Edward J.; Fraley, Mark E.

Agent Spruson & Ferguson

Pub. Number AU-A-2006335111

PCT Pub. Number WO2007/081572

Priority 60/755,986 04.01.06 US

Filing date 29 December 2006

Wipo publication date 19 July 2007

International Classifications

A61K 31/4745 (2006.01)

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/081572 Priority application(s): WO2007/081572

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp. 2007

26 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006335113-A method and apparatus for routing emergency calls in a VoIPsystem

2006335110-CETP inhibitors